Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Breast Cancer

Study Shows Need for Evidence-Based, Educational Material for Providers and Patients with Metastatic Breast Cancer

Study Shows Need for Evidence-Based, Educational Material for Providers and Patients with Metastatic Breast Cancer

BY KEVIN WRIGHT

Nurse Navigators Play a Vital Role for Breast Cancer Patients in the Oncology Clinic

Nurse Navigators Play a Vital Role for Breast Cancer Patients in the Oncology Clinic

BY JESSICA SKARZYNSKI

Prior CINV May Increase Occurrence in Later Cycles of Cancer Treatment

Prior CINV May Increase Occurrence in Later Cycles of Cancer Treatment

BY BRIELLE BENYON

Asian Patients With HR+, HER2- Breast Cancer Have Higher Recurrence Risk

Asian Patients With HR+, HER2- Breast Cancer Have Higher Recurrence Risk

BY KRISTI ROSA

FDA Approves Pembrolizumab Plus Chemo for TNBC

FDA Approves Pembrolizumab Plus Chemo for TNBC

BY BRIELLE BENYON

A Rundown of New Infusion Therapies

A Rundown of New Infusion Therapies

BY BRIELLE BENYON

Triple-Negative Breast Cancer Treatments Continue to Evolve

Triple-Negative Breast Cancer Treatments Continue to Evolve

BY HAYLEY VIRGIL

Nurses' Role in Cardiotoxicity in Cancer Survivors

Nurses' Role in Cardiotoxicity in Cancer Survivors

BY BRIELLE BENYON

Navigating Breast Cancer Care During a Pandemic

Navigating Breast Cancer Care During a Pandemic

BY CANCERCARE

FDA Advancements in HER2+ Breast Cancer

FDA Advancements in HER2+ Breast Cancer

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.